Results 261 to 270 of about 483,790 (291)

Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence and Associated Risk Factors in a Large Cohort of US Children. [PDF]

Open Forum Infect Dis
Katic BJ, Katragkou A, Alvitres JL, Gurumurthy M, Li C, Schwab JV, Hasan UN, Gaur S, Weller AS, Kennedy MC, DiPentima C, Rohan C, Richlin B, Chu D, Otero I, Patel A, Thomas P, Friedman SM.   +17 more
europepmc   +1 more source

Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial. [PDF]

J Infect Dis
Chew KW, McGinley B, Moser C, Li JZ, Evering TH, Ritz J, Javan AC, Margolis D, Wohl DA, Hughes MD, Daar ES, Currier JS, Eron JJ, Smith DM, Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-2/A5401 Study Team, Study Sites, and Investigators.   +16 more
europepmc   +1 more source

Effectiveness of N95 Mask Fit Testing for the Prevention of Severe Acute Respiratory Syndrome Coronavirus 2: A Retrospective Case-Control Study. [PDF]

Cureus
Fujimoto G, Obikane S, Kuboyama K.
europepmc   +1 more source

Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB-Containing Vaccines. [PDF]

J Infect Dis
Chalkias S, McGhee N, Whatley JL, Essink B, Brosz A, Tomassini JE, Girard B, Edwards DK, Wu K, Nasir A, Lee D, Avena LE, Feng J, Deng W, Montefiori DC, Baden LR, Miller JM, Das R.   +17 more
europepmc   +1 more source

Arteriovenous Thrombosis among Severe Acute Respiratory Syndrome Coronavirus 2 Infected Patients: An Observational Study at a University Hospital.

Ann Afr Med
AlAmri AS, AlShahrani MS, Hejazi TM, Abualola HA, Samarah AT, Almuaigel MF, AlDawsar FA, AlRashidi NS, AlGhamdi MA, Kabbani AH.   +9 more
europepmc   +1 more source

Coronavirus Disease 2019 Lineages in a Minimally Vaccinated Island Population: Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in Haiti. [PDF]

J Infect Dis
Mavian CN, Tagliamonte MS, Bassett M, Alam MT, Cash MN, Hitchings M, Louis R, Riva A, Zainabadi K, Deschamps MM, Liautaud B, Rouzier V, Fitzgerald DW, Pape JW, Morris JG, Salemi M.   +15 more
europepmc   +1 more source

Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants. [PDF]

J Infect Dis
Baum HE, Santopaolo M, Francis O, Milodowski EJ, Entwistle K, Oliver E, Hitchings B, Diamond D, Thomas AC, Mitchell RE, Kibble M, Gupta K, Di Bartolo N, Klenerman P, Brown A, Morales-Aza B, Oliver J, Berger I, Toye AM, Finn A, Goenka A, Davidson AD, Ring S, Molloy L, Lewcock M, Northstone K, Roth F, Timpson NJ, Wooldridge L, Halliday A, Rivino L.   +30 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Origins of Severe Acute Respiratory Syndrome-Coronavirus-2

Seminars in Respiratory and Critical Care Medicine, 2023
AbstractAn outbreak of severe pneumonia of unknown cause was identified in Wuhan, China in December 2019: the causative agent was a novel betacoronavirus, severe acute respiratory syndrome-cotonavirus-2 (SARS-CoV-2), a virus that joins a list of coronaviruses causing severe (e.g., SARS and Middle East respiratory syndrome) or milder (e.g., 229E, OC43 ...
openaire   +2 more sources

Severe-acute-respiratory-syndrome-coronavirus-2-mrna-vaccine

Reactions Weekly, 2023
  +10 more sources

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly